Summary
We compared the BCNU sensitivity of 4 freshly resected tumors (astrocytoma WM, and malignant gliomas MK, MB, and AM) and their clones to their karyology. The majority of primary cells in all 4 tumors had near-diploid chromosome numbers (2n±) and all were resistant to concentrations of BCNU exceeding 10μg/ ml. Followingin vitro cultivation, the cells from tumors WM and MB retained their 2n ± modal chromosome number with little change in the complexity of the karyotype. In contrast, tumors MK and AM demonstrated a more unstable genome. The modal chromosome number of MK shifted from 45 to 86 and that of tumor AM from 45 to 90. Karyotyping demonstrated additional ploidy changes and new marker chromosomes in both tumors. The colony forming assay (CFA) performed on thein vitro cultivated cells demonstrated little change in the sensitivity to BCNU in tumors WM and MB, while tumors MK and AM exhibited greater than a one log cell kill at 10.0μg/ml and 15.0μg/ml BCNU, respectively. The modal chromosome number and BCNU sensitivity followed a similar pattern in the 30 clones that were isolated; 21 clones with near-diploid and pseudodiploid chromosome numbers were all resistant to BCNU doses at or greater than 10μ/ml. In contrast, 9 clones isolated from the 3 malignant gliomas with 3n ± and 4n ± modal chromosome numbers were sensitive to this concentration of BCNU. The karyotypes of the hyperdiploid clones were more complex; they contained 5 or more ploidy changes and/or had marker chromosomes. These studies confirm the association of diploidy and BCNU-resistance in freshly resected malignant gliomas.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Shapiro JR, Pu P-Y, Mohamed AN, Galicich JH, Ebrahim SAD, Shapiro WR: Chromosome number and BCNU sensitivity in human gliomas. Cancer, in press, 1993
Shapiro JR, Yung W-KA, Shapiro WA: Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. Cancer Res 41: 2349–2359, 1981
Yung W-KA, Shapiro JR, Shapiro WR: Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. Cancer Res 42: 992–998, 1982
Asch AS, Leung LLK, Shapiro JR, Nachman RL: Human brain glial cells synthesize thrombospondin. Proc Natl Acad Sci USA 83: 2904–2908, 1986
ISCN: Harden DG, Klinger HP (eds), An International System for Human Cytogenetic Nomenclature. Published in collaboration with Cytogenet Cell Genet, 1985
Shapiro JR, Shapiro WR: The subpopulations and isolated cell types of freshly resected high grade human gliomas: Their influence on the tumor's evolutionin vivo and behavior and therapyin vitro. Cancer Metast Rev 4: 107–124, 1985
Shapiro JR: Cellular characterization and BCNU resistance of freshly resected and early passage human glioma cells. Prog Neuropathol 6: 133–143, 1986
Hoshino T, Wilson CB: Cell kinetic analysis of human malignant brain tumors (gliomas). Cancer 44: 956–962, 1979
Oksaka T, Therman E: Mitotic abnormalities and cancer. In: German JL (ed) Chromosomes and Cancer. John Wiley Sons, New York, 1974, pp 239–263
Therman E, Sarto GE, Stubblefield PA: Endomitosis: a reappraisal. Amer J Human Genet 63: 13–18, 1983
Wolman SR: Karyotypic progression in human tumors. Cancer Metast Rev 2: 257–293, 1983
Yamada K, Kondo T, Yoshioka M, Oami H: Cytogenetic studies in twenty human brain tumors: association of no. 22 chromosome abnormalities with tumors of the brain. Cancer Genet Cytogenet 2: 293–307, 1980
Saadi AA, Latimer F: Non-random chromosomal abnormalities in human brain tumors. Am J Hum Genet 32: 61A, 1980
Bigner SH, Mark J, Mahaley MS, Bigner DD: Patterns of the early, gross chromosomal changes in malignant human gliomas. Hereditas 101: 103–113, 1984
Bigner SH, Mark J, Bullard DE, Mahaley MSJ, Bigner DD: Chromosomal evolution in malignant human glioma starts with specific and usually numerical deviations. Cancer Genet Cytogenet 22: 121–135, 1986
Rey JA, Bello MJ, de Campos JM, Kusak ME, Ramos C, Benitez J: Chromosomal patterns in human malignant astrocytomas. Cancer Genet Cytogenet 29: 201–221, 1987
Rey JA, Bello MJ, de Campos JM, Kusak ME, Moreno S: Chromosomal composition of a series of 22 human lowgrade gliomas. Cancer Genet Cytogenet 29: 223–237, 1987
Rey JA, Bello MJ, de Campos JM, Kusak ME, Moreno S: On trisomy of chromosome 7 in human gliomas. Cancer Genet Cytogenet 29: 323–326, 1987
Bigner SH, Mark J, Burger PC, Mahaley MSJ, Bullard DE, Muhlbaier LH, Bigner DD: Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 48: 405–411, 1988
Jenkins RB, Kimmel DW, Moertel CA, Schultz CG, Scheithauer BW, Kelly PJ, Dewald GW: A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 39: 253–279, 1989
Rey JA, Bello MJ, de Campos JM, Kusak ME, Moreno S: Cytogenetic follow-up from direct preparation to advancedin vitro passages of a human malignant glioma. Cancer Genet. Cytogenet. 41: 175–183, 1989
Bigner SH, Mark J, Bigner DD: Cytogenetics of human brain tumors. Cancer Genet Cytogenet 47: 141–154, 1990
Arnoldus EPJ, Noordermeer IA, Peters ACB, Voormolen JHC, Bots GTAM, Raap AK, van der Ploeg M: Interphase cytogenetics of brain tumors. Genes, Chromosomes & Cancer 3: 101–107, 1991
Arnoldus EPJ, Noordermeer IA, Peters ACB, Raap AK, van der Ploeg M: Interphase cytogenetics reveals somatic pairing of chromosome 17 centromeres in normal human brain tissue but no trisomy 7 or sex-chromosome loss. Cytogenet Cell Genet 56: 214–216, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shapiro, J.R., Ebrahim, S.A.D., Mohamed, A.N. et al. BCNU-sensitivity in parental cells and clones from four freshly resected near-diploid human gliomas: An astrocytoma, an anaplastic astrocytoma and two glioblastomas multiforme. J Neuro-Oncol 15, 209–227 (1993). https://doi.org/10.1007/BF01050067
Issue Date:
DOI: https://doi.org/10.1007/BF01050067